{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:15:25Z","timestamp":1775020525141,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11916-022-01028-8","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:44:40Z","timestamp":1648809880000},"page":"323-330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrative, Interventional, and Non-invasive Approaches for the Treatment for Migraine During Pregnancy"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-9326","authenticated-orcid":false,"given":"Ashley","family":"Holdridge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deena E.","family":"Kuruvilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"issue":"1","key":"1028_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/head.14041","volume":"61","author":"IJ Saldanha","year":"2021","unstructured":"Saldanha IJ, Cao W, Bhuma MR, Konnyu KJ, Adam GP, Mehta S, Zullo AR, Chen KK, Roth JL, Balk EM.\u00a0Management of primary headaches during pregnancy, postpartum, and breastfeeding: A systematic review. Headache.\u00a02022;61(1):11\u201343.","journal-title":"Headache"},{"key":"1028_CR2","doi-asserted-by":"publisher","unstructured":"Grossman TB, Robbins MS, Govindappagari S, Dayal AK. Delivery outcomes of patients with acute migraine in pregnancy: a retrospective study. Headache. 2017.\u00a0https:\/\/doi.org\/10.1111\/head.13023","DOI":"10.1111\/head.13023"},{"issue":"10","key":"1028_CR3","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.mayocp.2020.06.053","volume":"95","author":"R Ishii","year":"2020","unstructured":"Ishii R, Schwedt TJ, Kim SK, Dumkrieger G, Chong CD, Dodick DW. Effect of migraine on pregnancy planning: insights from the American Registry for Migraine Research. In Mayo Clinic Proceedings 2020;95(10):2079\u20132089.","journal-title":"Mayo Clinic Proceedings. Mayo Clinic"},{"issue":"4","key":"1028_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10194-011-0329-1","volume":"12","author":"EV Kvisvik","year":"2011","unstructured":"Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain. 2011;12(4), 443\u2013451.","journal-title":"The Journal of Headache and Pain"},{"issue":"4","key":"1028_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.ncl.2019.06.001","volume":"37","author":"RC Burch","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4), 631\u2013649.","journal-title":"Neurologic Clinics"},{"key":"1028_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2018.03.011","author":"MW Green","year":"2018","unstructured":"Green MW, Rothrock JF. An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs \u201ccustomized\u201d dosing\/injection paradigm. Toxicon. 2018.\u00a0https:\/\/doi.org\/10.1016\/j.toxicon.2018.03.011","journal-title":"Toxicon"},{"key":"1028_CR7","doi-asserted-by":"crossref","unstructured":"\u2022 Burch R. Epidemiology and treatment of menstrual migraine and migraine during pregnancy and lactation: a narrative review. Headache. 2020.\u00a0This paper gives an updated review of the safety profile in pregnancy and lactation of Medications commonly used in migraine rescue and prevention.\u00a0","DOI":"10.1111\/head.13665"},{"key":"1028_CR8","unstructured":"CDC. Treating for two: medicine and pregnancy. 2021. (Accessed 1 May\u00a02021) Available at: https:\/\/www.cdc.gov\/pregnancy\/meds\/treatingfortwo\/index.html"},{"issue":"11","key":"1028_CR9","first-page":"713","volume":"41","author":"S Pernia","year":"2016","unstructured":"Pernia S, DeMaagd G.\u00a0The New Pregnancy and Lactation Labeling Rule. P&T: A Peer-Reviewed Journal for Formulary Management 2006;41(11):713\u2013715.","journal-title":"P & T: A Peer-Reviewed Journal for Formulary Management"},{"key":"1028_CR10","unstructured":"Food and Drug Administration,\u00a0US Department of Health and Human Service\u00a0(HHS). Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Federal Register. 2008;73(104):30831\u201330868. (Accessed date 1 May\u00a02021) Available at https:\/\/www.federalregister.gov\/documents\/2008\/05\/29\/E8-11806\/content-and-format-of-labeling-for-human-prescription-drug-and-biological-products-requirements-for"},{"issue":"1","key":"1028_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12906-021-03226-0","volume":"21","author":"DE Kuruvilla","year":"2021","unstructured":"Kuruvilla DE, Mehta A, Ravishankar N, Cowan RP. A patient perspective of complementary and integrative medicine (CIM) for migraine treatment: a social media survey. BMC Complementary Medicine and Therapies. 2021;21(1):58.","journal-title":"BMC Complementary Medicine and Therapies"},{"issue":"8","key":"1028_CR12","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/head.13148","volume":"57","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Dennis JA, Leach MJ, Bishop FL, Cramer H, Chung VC, Moore C, Lauche R, Cook R, Sibbritt D, Adams J. Complementary and alternative medicine use among US adults with headache or migraine: results from the 2012 National Health Interview Survey. Headache. 2017;57(8):1228\u20131242.","journal-title":"Headache"},{"issue":"4","key":"1028_CR13","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/jcpt.12548","volume":"42","author":"DF Thompson","year":"2017","unstructured":"Thompson DF, Saluja HS. Prophylaxis of migraine headaches with riboflavin: a systematic review. J Clin Pharm Ther. 2017;42(4), 394\u2013403.","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"1028_CR14","doi-asserted-by":"crossref","unstructured":"\u2022 Kuruvilla D, Wells RE. Evidence Based Integrative Treatments for Headache. Headache. 2019;59(6) 971\u2013972. This toolbox highlights evidence based integrative treatments for the treatment of headache disorders and reviews the possible adverse effects of these natural treatment approaches.","DOI":"10.1111\/head.13555"},{"key":"1028_CR15","doi-asserted-by":"crossref","unstructured":"Peikert A, Wilimzig C, K\u00f6hne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16 (4):257\u201363.","DOI":"10.1046\/j.1468-2982.1996.1604257.x"},{"key":"1028_CR16","doi-asserted-by":"crossref","unstructured":"Makrides M, Crosby D, Bain E, and Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database of Syst Rev.\u00a02014;4(April):CD000937.","DOI":"10.1002\/14651858.CD000937.pub2"},{"issue":"1","key":"1028_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12884-020-02935-7","volume":"20","author":"CA Ara\u00fajo","year":"2020","unstructured":"de Ara\u00fajo CA, Ray JG, Figueiroa JN, Alves JG. BRAzil magnesium (BRAMAG) trial: A double-masked randomized clinical trial of oral magnesium supplementation in pregnancy. BMC Pregnancy Childbirth. 2020;20(1):234.","journal-title":"BMC Pregnancy and Childbirth"},{"key":"1028_CR18","unstructured":"Magnesium sulfate Pregnancy and Breastfeeding Warnings. n.d. (Accessed 13 Mar 2022) https:\/\/www.drugs.com\/pregnancy\/magnesium-sulfate.html."},{"key":"1028_CR19","doi-asserted-by":"publisher","unstructured":"Numoto S, Hiroki K, Satoru T, Hiroko U, Tomoko K, Hirokazu K, Akihiko W, Yasumasa Y, Akihisa O. Effects of maternal magnesium sulfate treatment on newborns. Pediatr Int. 2021. https:\/\/doi.org\/10.1111\/ped.14747.","DOI":"10.1111\/ped.14747"},{"key":"1028_CR20","unstructured":"Institute of Medicine, Food and Nutrition Board, and A Report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press. 2000."},{"key":"1028_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/1028415x.2019.1572940","author":"M Parohan","year":"2020","unstructured":"Parohan M, Sarraf P, Javanbakht MH, Ranji-Burachaloo S, Djalali M. Effect of coenzyme Q10 supplementation on clinical features of migraine: A systematic review and dose\u2013response meta-analysis of randomized controlled trials. Nutr Neurosci. 2020.\u00a0https:\/\/doi.org\/10.1080\/1028415x.2019.1572940.","journal-title":"Nutritional Neuroscience"},{"issue":"1","key":"1028_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijgo.2008.11.033","volume":"105","author":"E Teran","year":"2009","unstructured":"Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet.\u00a02009;105(1):43\u201345.","journal-title":"International Journal of Gynaecology and Obstetrics: THe Official Organ of the International Federation of Gynaecology and Obstetrics"},{"key":"1028_CR23","doi-asserted-by":"crossref","unstructured":"\u2022 Ghorbani Z, Rafiee P, Fotouhi A, Haghighi S, Magham RR, Ahmadi ZS, Djalali M, Zareei M, Jahromi SR, Shahemi S, Mahmoudi M. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. J Headache Pain. 2020. 21(1):22.\u00a0This article suggests the possible role of Vitmain D in improving migraine via decreasing levels of CGRP.","DOI":"10.1186\/s10194-020-01090-w"},{"issue":"7\u20138","key":"1028_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.neurol.2019.12.008","volume":"176","author":"I Liampas","year":"2020","unstructured":"Liampas I, Siokas V, Brotis A, Dardiotis E. Vitamin D serum levels in patients with migraine: A meta-analysis. Revue Neurologique. 2020;176(7\u20138):560\u2013570.","journal-title":"Revue Neurologique"},{"issue":"1","key":"1028_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1097\/WNF.0000000000000419","volume":"44","author":"Y-F Zhang","year":"2021","unstructured":"Zhang YF, Xu ZQ, Zhou HJ, Liu YZ, Jiang XJ. The Efficacy of Vitamin D Supplementation for Migraine: A Meta-Analysis of Randomized Controlled Studies. Clin Neuropharmacol. 2021;44(1):5\u20138.","journal-title":"Clinical Neuropharmacology"},{"key":"1028_CR26","unstructured":"Vitamin D: Screening and supplementation during pregnancy. n.d. (Accessed 30 Apr\u00a02021)\u00a0https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2011\/07\/vitamin-d-screening-andsupplementation-during-pregnancy."},{"issue":"5","key":"1028_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4103\/2230-8210.139204","volume":"18","author":"A Mithal","year":"2014","unstructured":"Mithal A, Kalra S. Vitamin D supplementation in pregnancy. Indian J Endocrinol Metab. 2014;18(5), 593\u2013596.","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"issue":"10","key":"1028_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","volume":"87","author":"AL Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves AL, Ferreira AM, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention.\u00a0J Neurol Neurosurg Psychiatry. 2016;87(10):1127\u20131132.","journal-title":"Journal of Neurology, Neurosurgery, and PsYchiatry"},{"issue":"1","key":"1028_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12906-017-1933-7","volume":"17","author":"A Guilbot","year":"2017","unstructured":"Guilbot A, Bangratz M, Ait Abdellah S, Lucas C. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.\u00a0BMC Complement Altern Med. 2017;17(1):433.","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"1028_CR30","doi-asserted-by":"crossref","unstructured":"Negro A, Delaruelle Z, Ivanova TA, Khan S, Ornello R, Raffaelli B, Terrin A, Reuter U, Mitsikostas DD, EHF School of Advanced Studies (EHF-SAS). J Headache Pain\u00a02017;18(1):106.","DOI":"10.1186\/s10194-017-0816-0"},{"key":"1028_CR31","doi-asserted-by":"crossref","unstructured":"Lipchik GL, Smitherman TA, Penzien DB, Holroyd KA. Basic principles and techniques of cognitive\u2010behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache. 2006;46(Suppl 3):S119\u201332.","DOI":"10.1111\/j.1526-4610.2006.00563.x"},{"issue":"7","key":"1028_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1526-4610.2012.02189.x","volume":"52","author":"T-M Wallasch","year":"2012","unstructured":"Wallasch TM, Angeli A, Kropp P.\u00a0Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache\u00a02012;52(7):1094\u20131105.","journal-title":"Headache"},{"issue":"5","key":"1028_CR33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11916-002-0083-9","volume":"6","author":"KA Holroyd","year":"2002","unstructured":"Holroyd KA.\u00a0Behavioral and psychologic aspects of the pathophysiology and management of tension-type headache. Curr Pain Headache Rep\u00a02002;6(5):401\u2013407.","journal-title":"Current Pain and Headache Reports"},{"key":"1028_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2014.07.002","author":"PR Martin","year":"2014","unstructured":"Martin PR, Reece J, Callan M, MacLeod C, Kaur A, Gregg K, Goadsby PJ. Behavioral management of the triggers of recurrent headache: a randomized controlled trial.\u00a0Behav Res Ther.\u00a02014.\u00a0https:\/\/doi.org\/10.1016\/j.brat.2014.07.002.","journal-title":"Behaviour Research and Therapy"},{"issue":"5","key":"1028_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4103\/psychiatry.IndianJPsychiatry_144_20","volume":"62","author":"A Mehra","year":"2020","unstructured":"Mehra A, Grover S. Biofeedback intervention during the pregnancy for the treatment of anxiety disorder: A case report and review of literature. Indian J Psychiatry.\u00a02020;62(5):588\u2013590.","journal-title":"Indian Journal of Psychiatry"},{"issue":"2","key":"1028_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/head.13723","volume":"60","author":"N Zhang","year":"2020","unstructured":"Zhang N, Houle T, Hindiyeh N, Aurora SK. Systematic review: acupuncture vs standard pharmacological therapy for migraine prevention. Headache. 2020;60(2):309\u2013317.","journal-title":"Headache"},{"key":"1028_CR37","doi-asserted-by":"publisher","unstructured":"Knight, B. Specific point acupuncture for relief of morning sickness. n.d.\u00a0https:\/\/doi.org\/10.1186\/isrctn84841116.","DOI":"10.1186\/isrctn84841116"},{"key":"1028_CR38","doi-asserted-by":"publisher","DOI":"10.4172\/2327-5162.1000194","author":"SM Kwak","year":"2015","unstructured":"Kim SM, Kwak MA, Choi AR, Shin IH, Kim BS. The effects of acupuncture on insomnia, anxiety, and depression in women with chronic liver disease: A randomized controlled trial. Alternative and Integrative Medicine. 2015.\u00a0https:\/\/doi.org\/10.4172\/2327-5162.1000194.","journal-title":"Alternative & Integrative Medicine"},{"key":"1028_CR39","unstructured":"Tang YW, Cui X, Liu K, Li XX, Han S, Zhao J, Wang SY, Chen YY, Gao XY, Zhu B. Manual acupuncture stimulation of acupoints at the same and adjacent spinal segments promotes uterine contractility. Zhen ci yan jiu= Acupuncture Research. 2020;45(9):708\u201313."},{"issue":"1","key":"1028_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1055\/s-0040-1718842","volume":"12","author":"JN Mehta","year":"2021","unstructured":"Mehta JN, Parikh S, Desai SD, Solanki RC, Pathak AG. Study of additive effect of yoga and physical therapies to standard pharmacologic treatment in migraine. Journal of Neurosciences in Rural Practice. 2021;12(1):60\u201366.","journal-title":"Journal of Neurosciences in Rural Practice"},{"issue":"3","key":"1028_CR41","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/GRF.0000000000000210","volume":"59","author":"S Babbar","year":"2016","unstructured":"Babbar S, Shyken J.\u00a0Yoga in pregnancy. Clin Obstet Gynaecol.\u00a02016;59(3):600\u2013612.","journal-title":"Clinical Obstetrics and Gynecology"},{"issue":"6","key":"1028_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/09593985.2012.748114","volume":"29","author":"CW Ferreira","year":"2013","unstructured":"Ferreira CWS, Alburquerque-Sendi NF. Effectiveness of physical therapy for pregnancy-related low back and\/or pelvic pain after delivery: a systematic review.\u00a0Physiother Theory Pract. 2013;29(6):419\u2013431.","journal-title":"Physiotherapy Theory and Practice"},{"issue":"4","key":"1028_CR43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/jnnp.2007.124420","volume":"79","author":"A Ashkenazi","year":"2008","unstructured":"Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study.\u00a0J Neurol Neurosurg Psychiatry. 2008;79(4):415\u2013417.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"1028_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000000555","author":"S Govindappagari","year":"2014","unstructured":"Govindappagari S, Grossman TB, Dayal AK, Grosberg BM, Vollbracht S, Robbins MS. Peripheral nerve blocks in the treatment of migraine in pregnancy.\u00a0Obstet Gynecol.\u00a02014.\u00a0https:\/\/doi.org\/10.1097\/aog.0000000000000555.","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"1028_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/head.12053","volume":"53","author":"A Blumenfeld","year":"2013","unstructured":"Blumenfeld A, Ashkenazi A, Napchan U, Bender SD, Klein BC, Berliner R, Ailani J, et al. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches\u2013a narrative review. Headache\u00a02013;53(3):437\u2013446.","journal-title":"Headache"},{"key":"1028_CR46","doi-asserted-by":"publisher","unstructured":"Blumenfeld A, Ashkenazi A, Grosberg B, Napchan U, Narouze S, Nett B, DePalma T, Rosenthal B, et al.\u00a0Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: results of the American Headache Society Interventional Procedure Survey (AHS-IPS). Headache. 2010. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01676.x.","DOI":"10.1111\/j.1526-4610.2010.01676.x"},{"issue":"4","key":"1028_CR47","first-page":"653","volume":"65","author":"DJ Alvarez","year":"2002","unstructured":"Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician\u00a02002;65(4):653\u2013660.","journal-title":"American Family Physician"},{"key":"1028_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1746-160x-4-32","author":"EP Calandre","year":"2008","unstructured":"Calandre EP, Hidalgo J, Garcia-Leiva JM, Rico-Villademoros F, Delgado-Rodriguez A. Myofascial trigger points in cluster headache patients: a case series.\u00a0Head Face Med.\u00a02008. https:\/\/doi.org\/10.1186\/1746-160x-4-32.","journal-title":"Head & Face Medicine"},{"key":"1028_CR49","doi-asserted-by":"crossref","unstructured":"Robbins MS, Kuruvilla D, Blumenfeld A, Charleston IV L, Sorrell M, Robertson CE, Grosberg BM, Bender SD, Napchan U, Ashkenazi A. Trigger point injections for headache disorders: expert consensus methodology and narrative review. Headache. 2014;54(9):1441-59.","DOI":"10.1111\/head.12442"},{"issue":"5","key":"1028_CR50","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S1098-7339(97)80035-1","volume":"22","author":"LC Tsen","year":"1997","unstructured":"Tsen LC, Camann WR. Trigger point injections for myofascial pain during epidural analgesia for labor. Reg Anesth.\u00a01997;22(5):466\u2013468.","journal-title":"Regional Anesthesia"},{"issue":"May","key":"1028_CR51","first-page":"2516953","volume":"2018","author":"M Binfalah","year":"2018","unstructured":"Binfalah M, Alghawi E, Shosha E, Alhilly A, Bakhiet M. Sphenopalatine ganglion block for the treatment of acute migraine headache.\u00a0Pain Res Treat.\u00a02018(May):2516953.","journal-title":"Pain Research and Treatment"},{"issue":"7","key":"1028_CR52","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1526-4610.2003.03127.x","volume":"43","author":"D Yarnitsky","year":"2003","unstructured":"Yarnitsky D, Goor\u2010Aryeh I, Bajwa ZH, Ransil BI, Cutrer FM, Sottile A, Burstein R. 2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache: The journal of head and face pain. 2003;43(7):704\u2013714.","journal-title":"Headache"},{"key":"1028_CR53","doi-asserted-by":"publisher","unstructured":"Candido KD. A novel revision to the classical transnasal topical sphenopalatine ganglion block for the treatment of headache and facial pain. Pain Physician. 2013.\u00a0https:\/\/doi.org\/10.36076\/ppj.2013\/16\/e769.","DOI":"10.36076\/ppj.2013\/16\/e769"},{"issue":"2","key":"1028_CR54","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1213\/XAA.0000000000000722","volume":"11","author":"D Levin","year":"2018","unstructured":"Levin D, Cohen S, Mellender S, Kiss G. Sphenopalatine ganglion block successfully treats migraines in a type 1 Arnold Chiari malformation pregnant patient: a case report. A&A Practice. 2018;11(2), 32\u201334.","journal-title":"A&a Practice"},{"key":"1028_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.063792","author":"JC Morgan","year":"2006","unstructured":"Morgan JC. Botulinum toxin A during pregnancy: A survey of treating physicians. J Neurol Neurosurg Psychiatry.2006.\u00a0https:\/\/doi.org\/10.1136\/jnnp.2005.063792.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry."},{"key":"1028_CR56","doi-asserted-by":"crossref","unstructured":"Brin MF, Kirby RS, Slavotinek A, Miller\u2010Messana MA, Parker L, Yushmanova I, Yang H. Pregnancy outcomes following exposure to onabotulinumtoxinA. Pharmacoepidemiol Drig Saf.\u00a02016.","DOI":"10.1002\/pds.3920"},{"key":"1028_CR57","doi-asserted-by":"crossref","unstructured":"\u2022 Wong HT, Khalil M, Ahmed F. OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients. J Headache Pain. 2020;21(1):129. This study reviews the largest cohort of people with migraine documented who received botox during pregnancy to date.","DOI":"10.1186\/s10194-020-01196-1"},{"key":"1028_CR58","doi-asserted-by":"crossref","unstructured":"\u2022 Robinson AY, Grogan PM. OnabotulinumtoxinA successfully used as migraine prophylaxis during pregnancy: a case report. Mil Med. 2014;179(6):e703-4.\u00a0Longest reported follow-up period for a child whose mother received BoNTA during pregnancy.","DOI":"10.7205\/MILMED-D-13-00477"},{"key":"1028_CR59","doi-asserted-by":"crossref","unstructured":"Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial. Cephalalgia. 2019;39(1):3\u201314.","DOI":"10.1177\/0333102418811573"},{"issue":"8","key":"1028_CR60","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/head.13551","volume":"59","author":"D Yarnitsky","year":"2019","unstructured":"Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, Lin T, Silberstein SD. Remote electrical neuromodulation (REN) relieves acute migraine: A randomized, double\u2010blind, placebo\u2010controlled, multicenter trial. Headache. 2019;59(8):1240\u20131252.","journal-title":"Headache"},{"issue":"17 Suppl","key":"1028_CR61","first-page":"S317","volume":"23","author":"M Mwamburi","year":"2017","unstructured":"Mwamburi M, Liebler EJ, Tenaglia AT. Review of non-invasive vagus nerve stimulation (gammaCore): efficacy, safety, potential impact on comorbidities, and economic burden for episodic and chronic cluster headache.\u00a0Am J Manag Care. 2017;23(17 Suppl):S317\u2013S325.","journal-title":"The American Journal of Managed Care"},{"key":"1028_CR62","doi-asserted-by":"crossref","unstructured":"Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain. 2016;139(Pt 7):2002\u201314.","DOI":"10.1093\/brain\/aww118"},{"key":"1028_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2021.1908122","author":"O Daniel","year":"2021","unstructured":"Daniel O, Sharon R, Tepper SJ. A device review of Relivion\u00ae: An external combined occipital and trigeminal neurostimulation (eCOT-NS) system for self-administered treatment of migraine and major depressive disorder.\u00a0Expert Rev Med Devices.\u00a02021.\u00a0https:\/\/doi.org\/10.1080\/17434440.2021.1908122.","journal-title":"Expert Review of Medical Devices"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01028-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-022-01028-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-022-01028-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T12:14:13Z","timestamp":1649938453000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-022-01028-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1007\/s11916-022-01028-8","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"4 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Holdridge serves on the advisory boards for Amgen, Teva, and Lundbeck. She is on the speaker\u2019s bureau for Allergan\/Abbvie, Amgen\/Novartis, Biohaven, Lilly, Lundbeck, and Teva pharmaceuticals. Dr. Kuruvilla serves on the advisory boards for Theranica, Allergan\/Abbvie, Lilly, Amgen\/Novartis. She is a consultant for Alphasites consulting, Cefaly, Neurolief, Theranica, Nowwhat media, KX advisors. She is on the speaker\u2019s bureau for Allergan\/Abbvie, Lilly, Amgen\/Novartis, Biohaven, American headache society, CME meeting. She has provided clinical trial support for Cefaly and Neurolief. She is on the editorial board for Healthline and a contributing author for Headline and WebMD\/Medscape. Dr. Johnson serves on the advisor boards for Lundbeck, Teva, and Lilly. She is on the speaker\u2019s bureau for Allergan\/Abbvie, Biohaven, Lundbeck, Lilly, and Teva pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}